REFERENCES
- Cooper J R. Methadone treatment and acquired immunodeficiency syndrome. JAMA 1989; 262: 1664–1668
- Hser Y-I, Hoffman V, Grella C E, Anglin M D. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry 2001; 58: 503–508
- Kinlock T W, Hanlon T E, Nurco D N. Heroin use in the United States: History and present developments. Heroin in the Age of Crack-Cocaine, J A Inciardi, L Harrison. Sage, Thousand Oaks, Calif. 1998; 1–30
- Woodward A, Epstein J, Gfroerer J, Melnick D, Thoreson R, Wilson D. The drug abuse treatment gap: Recent estimates. Health Care Financ Rev 1997; 18: 5–17
- Hunt D E, Lipton D S, Goldsmith D S, Strug D C, Spunt B. “It takes your heart”: The view of methadone maintenance in the addict world and its effect on recruitment into treatment. International Journal of the Addictions 1985; 20: 1751–1771
- Stancliff S, Myers J E, Steiner S, Drucker E. Beliefs about methadone in an inner-city methadone clinic. J Urban Health 2002; 79: 571–578
- Dole V P, Nyswander M. A medical treatment for diacetylmorphine (heroin addiction): A clinical trial with methadone hydrochloride. JAMA 1965; 193: 646–650
- Zweben J E, Sorensen J L. Misunderstandings about methadone. J Psychoactive Drugs 1988; 20: 275–281
- Brown B S, Benn G J, Jansen D R. Methadone maintenance: Some client opinions. Am J Psychiatry 1975; 132: 623–626
- Brown B S, Jansen D R, Benn G J. Changes in attitude toward methadone. Arch Gen Psychiatry 1975; 32: 214–218
- Bovelle E I, Taylor A. Conclusions and implications. Life with Heroin – Voices from the Inner City, B Hanson, G Beschner, J M Walters, E I Bovelle. Lexington Books, Lexington, Mass. 1984; 175–185
- Jansen D R, Brown B S, Bass U F. Comparison of attitudes and beliefs about methadone of clients retained and lost to treatment. Drug Forum 1974; 3: 215–223
- Kayman D J, Goldstein M F, Deren S, Rosenblum A. Predicting treatment retention with a brief “Opinions about Methadone” scale. J Psychoactive Drugs 2006; 38: 93–100
- Rieckmann T, Daley M, Fuller B E, Thomas C, McCarty D. Client and counselor attitudes toward the use of medications for treatment of opioid dependence. J Subst Abuse Treat 2007; 32: 207–215
- Jones H E. Practical considerations for the clinical use of buprenorphine. Science & Perspectives August, 2004; 4–20
- Johnson R E, Strain E C, Amass L. Buprenorphine: How to use it right. Drug Alcohol Depend 2003; 70: S59–S77
- Peterson J A, Schacht-Reisinger H S, Schwartz R P, et al. Targeted sampling in drug abuse research: A review and case study. Journal of Field Methods 2008; 20: 155–170
- McLellan A T, Alterman A L, Woody G E, Metzger D. A quantitative measure of substance abuse treatments: The Treatment Services Review. J Nerv Ment Dis 1992; 180: 101–110
- Agar M H. The Professional Stranger: An Informal Introduction to Ethnography. Academic Press, New York 1996
- Schwartz R P, Kelly S M, O'Grady K E, et al. In-treatment v. out-of-treatment opioid dependent adults: Drug use and criminal history. Am J Drug Alcohol Abuse 2008; 34: 17–28
- Rosenblum A, Magura S, Joseph H. Ambivalence toward methadone treatment among intravenous drug users. J Psychoactive Drugs 1991; 23: 21–27
- White W, Coon B. Methadone and the anti-medication bias in addiction treatment. Counselor 2003; 4: 58–63